Vanberra Signal

Genome Carver

Curated by Signal

Provider of software platform for synthetic genomics

Overview

Genome Carver is a synthetic genomics project conceived as part of the laboratory of Patrick Cai at the University of Edinburgh. Genome Carver allows users to extract coding sequences, including regulatory elements from genomes, package the sequences according to any standard, analyze and remove forbidden restriction sites, codon optimize the sequences for different target organisms/genomes, and generate PCR primers for the packaged sequences for amplification or large scale production. The project is being run by Emily Scher, a graduate student at the Cai lab.

Key facts

Founded
2017

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Provider of genetic counseling and genetic cancer testing services

    Life Sciences TechnologyCambridge, United Kingdom
  • Provider of a platform for detection of lung cancer

    Life Sciences TechnologyOxford, United Kingdom
  • Developer of patient-specific surgical treatments for orthopedic disorders

    Life Sciences TechnologyBath, United Kingdom

About Genome Carver

What does Genome Carver do?

Genome Carver is a synthetic genomics project conceived as part of the laboratory of Patrick Cai at the University of Edinburgh.

Where is Genome Carver headquartered?

Genome Carver is headquartered in Edinburgh, United Kingdom.

When was Genome Carver founded?

Genome Carver was founded in 2017.

Which sector is Genome Carver in?

Genome Carver operates in Life Sciences Technology.

Who are Genome Carver's competitors?

Companies similar to Genome Carver include GeneHealth, Oxford Cancer Analytics, and Orthoscape.